Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm

Overview of attention for article published in Frontiers in endocrinology, November 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 29,081 followers.

RT @FrontEndocrinol: New Research: Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid…

22 Nov 2023

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid…

21 Nov 2023

Reply Repost Favourite

RT @jimsarsagat: Authors’ conclusions: FRAX is suitable for postoperative DTC patients after TSH suppressive therapy. In the absence of BMD…

21 Nov 2023

Reply Repost Favourite

Authors’ conclusions: FRAX is suitable for postoperative DTC patients after TSH suppressive therapy. In the absence of BMD, TSH weighted by age can improve the specificity of FRAX in the diagnosis of osteoporosis in this population. #osteoporosis #thyroid

21 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.